Morgan Stanley Maintains Underweight on DT Midstream, Raises Price Target to $64
Morgan Stanley analyst Robert Kad maintains DT Midstream (NYSE:DTM) with a Underweight and raises the price target from $60 to $64.
Barclays Maintains Overweight on DT Midstream, Lowers Price Target to $63
Barclays analyst Theresa Chen maintains DT Midstream (NYSE:DTM) with a Overweight and lowers the price target from $65 to $63.
These 2 High Yielders Could Benefit From The Supply Crunch Caused By The Russia-Ukraine War
Since the Energy Select Sector SPDR FUN (ARCA: XLE) is down roughly 16% over the past month, it may be a good time to shop around for oversold equities in the oil and gas sector. Although investors are concerned about a recession slowing down the economy, natural gas prices are still at record highs.
DT Midstream to Acquire an Additional 26.25% Ownership Interest in Millennium Pipeline for About $552M in Cash
DT Midstream, Inc. (NYSE: DTM) today announced that it has entered into an agreement to acquire an additional 26.25% ownership interest in Millennium Pipeline for approximately $552 million in cash.
Barclays Maintains Overweight on DT Midstream, Raises Price Target to $62
Barclays analyst Theresa Chen maintains DT Midstream (NYSE:DTM) with a Overweight and raises the price target from $59 to $62.
Mizuho Maintains Buy on DT Midstream, Raises Price Target to $58
Mizuho analyst Robert Mosca maintains DT Midstream (NYSE:DTM) with a Buy and raises the price target from $57 to $58.
DT Midstream: Q2 Earnings Insights
DT Midstream (NYSE:DTM) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Wells Fargo Maintains Overweight on DT Midstream, Raises Price Target to $59
Wells Fargo analyst Michael Blum maintains DT Midstream (NYSE:DTM) with a Overweight and raises the price target from $58 to $59.
Morgan Stanley Maintains Underweight on DT Midstream, Raises Price Target to $60
Morgan Stanley analyst Robert Kad maintains DT Midstream (NYSE:DTM) with a Underweight and raises the price target from $54 to $60.